- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Organ-on-a-chip models for development of cancer immunotherapies ; volume:72 ; number:12 ; day:3 ; month:11 ; year:2023 ; pages:3971-3983 ; date:12.2023
Cancer immunology immunotherapy ; 72, Heft 12 (3.11.2023), 3971-3983, 12.2023
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-023-03572-7
- URN
-
urn:nbn:de:101:1-2024022307483416279927
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chernyavska, M.
- Masoudnia, M.
- Valerius, Thomas
- Verdurmen, W. P. R.
- SpringerLink (Online service)
Other Objects (12)
Neurotoxicity of novel cancer immunotherapies
Advances in Prostate Cancer Immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
Development of NK cell-based cancer immunotherapies through receptor engineering
Computational methods to improve development of T cell based cancer immunotherapies
Clinical landscape of macrophage-reprogramming cancer immunotherapies
Cancer immunotherapies targeting the PD-1 signaling pathway
Immersion in the search for effective cancer immunotherapies
Revolutionizing cancer treatment: the rise of personalized immunotherapies
Immunotherapies for pediatric cancer: current landscape and future perspectives
Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives
Immunotherapies in solid tumors
Neurotoxicity of novel cancer immunotherapies
Advances in Prostate Cancer Immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
Development of NK cell-based cancer immunotherapies through receptor engineering
Computational methods to improve development of T cell based cancer immunotherapies
Clinical landscape of macrophage-reprogramming cancer immunotherapies
Cancer immunotherapies targeting the PD-1 signaling pathway
Immersion in the search for effective cancer immunotherapies
Revolutionizing cancer treatment: the rise of personalized immunotherapies
Immunotherapies for pediatric cancer: current landscape and future perspectives
Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives
Immunotherapies in solid tumors
Neurotoxicity of novel cancer immunotherapies
Advances in Prostate Cancer Immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
Development of NK cell-based cancer immunotherapies through receptor engineering
Computational methods to improve development of T cell based cancer immunotherapies
Clinical landscape of macrophage-reprogramming cancer immunotherapies
Cancer immunotherapies targeting the PD-1 signaling pathway
Immersion in the search for effective cancer immunotherapies
Revolutionizing cancer treatment: the rise of personalized immunotherapies
Immunotherapies for pediatric cancer: current landscape and future perspectives
Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives